Bliss GVS Pharma Ltd BLISSGVS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- INR 101.05
- Day Range
- INR 101.75–106.20
- 52-Week Range
- INR 73.30–149.60
- Bid/Ask
- INR 105.20 / INR 105.95
- Market Cap
- INR 11.02 Bil
- Volume/Avg
- 299,193 / 405,624
Key Statistics
- Price/Earnings (Normalized)
- 12.43
- Price/Sales
- 1.45
- Dividend Yield (Trailing)
- 0.48%
- Dividend Yield (Forward)
- 0.48%
- Total Yield
- 0.48%
Company Profile
Bliss GVS Pharma Ltd is an India-based company engaged in the manufacturing, marketing, trading, and export of pharmaceutical products. Geographically, it derives a majority of revenue from Outside India. Some of its brands include Lonart, P-Alaxin, Funbact, and Lofnac, and others. It offers pharma products including tablets, suspensions, suppositories, and injections. The majority of its revenue is derived from Exports.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 763
- Website
- https://www.blissgvs.com
Comparables
Valuation
|
Metric
|
BLISSGVS
|
500288
|
524348
|
|---|---|---|---|
Price/Earnings (Normalized) | 12.43 | 25.53 | 27.64 |
Price/Book Value | 1.14 | 2.90 | 3.67 |
Price/Sales | 1.45 | 1.45 | 1.86 |
Price/Cash Flow | 7.79 | 19.24 | 20.91 |
Price/Earnings
BLISSGVS
500288
524348
Financial Strength
|
Metric
|
BLISSGVS
|
500288
|
524348
|
|---|---|---|---|
Quick Ratio | 3.97 | 0.95 | 0.91 |
Current Ratio | 5.08 | 2.23 | 1.66 |
Interest Coverage | 17.91 | 30.56 | 8.03 |
Quick Ratio
BLISSGVS
500288
524348
Profitability
|
Metric
|
BLISSGVS
|
500288
|
524348
|
|---|---|---|---|
Return on Assets (Normalized) | 8.07% | 8.07% | 7.10% |
Return on Equity (Normalized) | 10.38% | 12.15% | 13.89% |
Return on Invested Capital (Normalized) | 9.49% | 12.08% | 10.74% |
Return on Assets
BLISSGVS
500288
524348
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| Dgrlkdhzb | Mkhqzt | $81.1 Bil | |||
| Zoetis Inc Class A
ZTS
| Vvvyltlxln | Bksx | $80.7 Bil | |||
| Haleon PLC ADR
HLN
| Zyghrdln | Zmvkt | $38.6 Bil | |||
| Viatris Inc
VTRS
| Jtsgwslg | Xfh | $12.5 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Qhljxqss | Llcq | $12.1 Bil | |||
| Catalent Inc
CTLT
| Pqqfcngj | Jkvvdq | $10.2 Bil | |||
| Perrigo Co PLC
PRGO
| Cmnpfmnv | Dqdq | $3.7 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Cxfzqzmf | Gknx | $3.4 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Rsghxjwql | Ryrtg | $3.3 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Zblnhtnzlf | Fjbct | $2.9 Bil |